Business
Bio Spectrum
Centre announces winners of Padma Awards 2025
The government has announced Padma Awards - one of the highest civilian Awards of the country, on January 25.
1 min |
March 2025
Bio Spectrum
UPES announces strategic partnership with Medical University of the Americas
The School of Health Sciences and Technology (SOHST) at UPES, a multi-disciplinary university in India, has announced a strategic first-of-its-kind partnership with the Medical University of the Americas (MUA).
1 min |
March 2025
Bio Spectrum
"We are expanding our single-use solutions portfolio with next-gen innovations that directly address industry needs"
With a five-year vision to establish Shah Brothers as the most trusted and innovative partner for single-use technologies in India, the company is making aggressive investments in expanding its manufacturing footprint, enhancing customer engagement, and building a world-class team.
2 min |
March 2025
Bio Spectrum
Dr Cyrus S. Poonawalla receives 2nd Dr. K. Anji Reddy Memorial Fellowship
The Institute of Chemical Technology (ICT Mumbai), under its flagship initiative, the Mumbai Biocluster, has awarded 2nd Dr. K. Anji Reddy Memorial Fellowship for Affordable Biopharmaceuticals to Dr Cyrus S. Poonawalla, Chairman, Serum Institute of India, a revolutionary entrepreneur, in recognition of his exceptional contributions to biopharmaceutical innovation and global healthcare. Dr Cyrus S. Poonawalla’s extraordinary contributions to global healthcare have established India as a hub for affordable vaccines, saving billions of lives worldwide.
1 min |
March 2025
Bio Spectrum
How India's Vaccine Renaissance Rests on Innovative & Equitable Solutions
Thanks to its strong R&D ecosystem and smart partnerships, India will be able to play a bigger role in redefining global health equality by making innovative vaccines accessible. The Indian vaccine environment will undergo a dramatic transformation in the next few years due to a spike in investments in innovative vaccine technologies, production platforms, and logistics solutions.
5 min |
March 2025
Bio Spectrum
Dvara Health Finance, IIHMR unveil diploma in community health and digital healthcare operations
Dvara Health Finance (DHF) and the Institute of Health Management Research (IIHMR), Bengaluru, have signed a Memorandum of Understanding (MoU) to jointly develop and launch a Diploma in Community Health and Digital Healthcare Operations.
1 min |
March 2025
Bio Spectrum
Revvity unveils revolutionary solution for cellular imaging
Revvity, Inc. has unveiled its groundbreaking new Phenologic.AI software. Designed to redefine cellular imaging workflows for Revvity’s Harmony and Signals Image Artist software packages, the Phenologic.AI software leverages pre-trained deeplearning models to analyse brightfield images, providing an additional multiplexing channel and streamlined workflows for live cell analysis.
1 min |
March 2025
Bio Spectrum
INST Mohali develops drug delivery system to revolutionise treatment of Rheumatoid Arthritis
Researchers from Institute of Nano Science and Technology (INST) Mohali, an autonomous institution of the Department of Science and Technology (DST), have developed an innovative “self-actuating” drug delivery system that could revolutionise the treatment of rheumatoid arthritis (RA) by targeting inflammation directly within the joints so that therapeutic agents are released only when needed.
1 min |
March 2025
Bio Spectrum
IIT-G designs multistage clinical trial method for revolutionising personalised medical care.
Researchers at the Indian Institute of Technology Guwahati (IIT-G), in collaboration with leading institutions worldwide, have developed an innovative multi-stage clinical trial method aimed at revolutionising personalised medical care.
1 min |
March 2025
Bio Spectrum
GV Research Platform and BeCytes partner to advance biopharma research in India
Hyderabad-based GV Research Platform (GVRP), a leading provider of preclinical research solutions, has announced a strategic partnership with Spanish startup BeCytes Biotechnologies to expand access to high-quality human and animal-derived biological materials for drug discovery and toxicology research in India.
1 min |
March 2025
Bio Spectrum
"Our goal is to make new molecules with new mutations to develop an RSV vaccine in India"
Dr Raghavan Varadarajan, Professor, Indian Institute of Science (IISc), Bengaluru has won the Tata Transformation Prize 2024 in the healthcare category, with a prize money of Rs 2 crore.
2 min |
March 2025
Bio Spectrum
Intuitive announces new Vice President and General Manager in India
Medtech firm Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, has announced its appointment of Rohitt Mahajan as vice president and general manager for India.
1 min |
March 2025
Bio Spectrum
VFL Sciences announces cooperation with RocGene Technology
Chennai-based VFL Sciences and RocGene Technology, based in China, have signed an agreement of cooperation wherein VFL Sciences will exclusively sell the entire range of products from RocGene in India.
1 min |
March 2025
Bio Spectrum
"Quality shouldn't be an afterthought but an integral part of manufacturing process"
At the 63rd Annual Day Celebrations of the Indian Drug Manufacturers' Association (IDMA) held in Mumbai on February 8, Dr Rajeev Raghuvanshi, Drugs Controller General of India (DCGI), emphasised the importance of execution over excessive regulation.
2 min |
March 2025
Bio Spectrum
PPPs Transforming Chronic Diseases Burden Among Indian Women
More and more Indian health research institutions and the World Health Organization (WHO) are realising that medical interventions alone are insufficient to alleviate the burden of chronic diseases among women.
4 min |
March 2025
Bio Spectrum
Centre establishes India's first Ferret Research Facility at THSTI
India's commitment to cutting-edge biomedical research and innovation has taken a significant leap forward with the dedication of the nation's first Ferret Research Facility at the Translational Health Science and Technology Institute (THSTI) in the NCR Biotech Science Cluster, Faridabad.
1 min |
March 2025
Bio Spectrum
Amit Agrawal steps in as new Pharmaceuticals Secretary
Amit Agrawal, the Chief Executive Officer (CEO) of the Unique Identification Authority of India (UIDAI), has been appointed as the new Secretary of the Department of Pharmaceuticals, Government of India.
1 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
IIT-B joins hands with Tohoku University to offer MTech, PhD dual degree programmes
The Indian Institute of Technology, Bombay (IIT-B) has entered into a Memorandum of Understanding (MoU) with Japan's Tohoku University to launch the IIT Bombay-Tohoku University Joint Academic & Research Programme.
1 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
Innovative injectable hydrogel to offer targeted breast cancer therapy
In a multi-institutional research led by researchers from Indian Institute of Technology Guwahati (IIT-G) and Bose Institute Kolkata, an advanced injectable hydrogel has been developed for localised cancer treatment.
1 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
Bio-Techne, Waters ink co-marketing agreement for biotherapeutic characterisation
American life sciences company Bio-Techne Corporation, a leader in automated platforms for biotherapeutic characterisation, has announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the reach of advanced biotherapeutic characterisation and development processes.
1 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
Nano-formulation of darkness hormone to serve as therapeutic solution for Parkinson's disease
Scientists from Institute of Nano Science and Technology (INST) Mohali have proved that nano-formulation of Melatonin, the hormone produced by the brain in response to darkness, showed improved antioxidative and neuroprotective properties and could be a potential therapeutic solution for Parkinson's disease (PD).
1 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
"Govt should facilitate low-interest loans or VC funding specifically for biopharma startups & small enterprises"
\"In a recent development, Nagpur-based biotech company GeNext Genomics (GNG) has joined -hands with Merck Life Science to support the Indian biotech system, particularly in the area of biomanufacturing, which is garnering more attention after the approval of the BioE3 policy.Supriya Kashikar, Founder & Chief Executive Officer, GeNext Genomics shares her views with BioSpectrum on the growth of biomanufacturing sector in India, and how the company plans to play a relevant role in this aspect.
4 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
Redcliffe Labs reinforces strategic leadership as Aditya Kandoi steps into CEO role, Dheeraj Jain as Chairman
Redcliffe Labs, a purpose-driven pan-India omnichannel diagnostics service provider, has announced a strategic leadership transition.
1 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
Zyla Health on-boards Rohit Boda as Advisor
Gurugram-based Zyla Health, a care management platform, has announced the onboarding of renowned industry leader, Rohit Boda, to the Board of Advisors.
1 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
Claypond Capital appoints Shravan Subramanyam to lead medtech platform
Claypond Capital, the family investment office of Dr Ranjan Pai, has announced the appointment of Dr Shravan Subramanyam as the head of its medical technology platform.
1 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
How AI Innovations at GCCs Solidifying India's Position in Global Life Sciences Industry
India's life sciences sector is undergoing a major transformation, led by the expansion of Global Capability Centres GCCs). These centres, which serve as strategic hubs for multinational companies in pharmaceuticals, biotechnology, and healthcare, are strengthening India's role in the global life sciences landscape. Currently, there are over 95 life sciences GCCs in India, employing approximately 280,000 professionals. By 2030, this number is projected to reach 160 GCCs and around 420,000 employees. Advancements in artificial intelligence AI) are central to this transformation, driving innovation across drug discovery and clinical research. India's life sciences GCCs have evolved from operational support centres to world-class R&D engines, leveraging India’s robust talent pool, advanced technology adoption, and cost advantages. These GCCs are driving the future of Al-powered drug discovery and clinical research. Let’s explore further.
4 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
Attaining OpEx is crucial for maintaining sustainability and competitiveness
The pharmaceutical industry in India is at a critical juncture, full of enormous promise and substantial responsibilities. The stakes are great and the world stage is prepared. A continual improvement approach, supported by investments in talent, technology, and teamwork, is essential for success. Companies that want to prosper in this changing environment must address operational excellence (OpEx) issues, change supply chains, and promote an innovative culture.
4 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
AIIMS signs MoU with Wipro GE Healthcare to establish 'AI Health Innovations Hub'
All India Institute of Medical Sciences (AIIMS), New Delhi, has signed a Memorandum of Understanding (MoU) with Wipro GE Healthcare, a leading global provider of healthcare technologies, to establish an AI Health Innovations Hub.
1 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
Asia Healthcare Holdings receives additional $150 M investment from GIC
Asia Healthcare Holdings (AHH), the single specialty hospitals focused healthcare platform backed by GIC and TPG, has announced that GIC, Singapore's sovereign wealth fund, will invest an additional $150 million in AHH.
1 min |
BioSpectrum Indian Feb 2025
Bio Spectrum
New method for detecting H. pylori can help dyspeptic patients in remote settings
Researchers at CSIR- Institute of Genomics & Integrative Biology (IGIB) have found a way to develop FELUDA as a point-of-care diagnostic service at a minimal cost for detection of H. pylori and its mutations in dyspeptic patients from rural areas of India, with minimal or no access to diagnostic laboratories.
1 min |